NCT00567008View on ClinicalTrials.gov

Chantix for Treating Cocaine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Cocaine Dependence
Interventions
DRUG

varenicline

1.0 mg BID for 8 weeks

DRUG

placebo

placebo BID for 8 weeks

Trial Locations (1)

19104 6178

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pennsylvania

OTHER

NCT00567008 - Chantix for Treating Cocaine Dependence | Biotech Hunter | Biotech Hunter